The Safety and Efficacy of Salvage Stereotactic Radiation Therapy in Patients with Intraprostatic Tumor Recurrence After Previous External Radiation Therapy: Phase 1 Results from the GETUG-AFU 31 Study.
Fiche publication
Date publication
février 2023
Journal
European urology oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr CORMIER Luc, Pr PEIFFERT Didier, Dr QUIVRIN Magali
Tous les auteurs :
Pasquier D, Lacornerie T, Supiot S, Pommier P, Quivrin M, Simon JM, Loos G, Meyer E, Calais G, Peiffert D, Vandendorpe B, Aymes E, Leguillette C, Brihoum M, Nenan S, Cormier L, Le Deley MC, Lartigau EF
Lien Pubmed
Résumé
There is no consensus on the best local salvage treatment for prostate cancer recurrence after primary external beam radiotherapy. Prospective data on stereotactic body radiation therapy (SBRT) are very scarce.
Mots clés
Local recurrence, Phase 1, Prostate cancer, Radiation therapy, Reirradiation, Salvage stereotactic body radiation therapy, Stereotactic body radiation therapy
Référence
Eur Urol Oncol. 2023 02 6;: